Aster DM Healthcare Ltd disclosed that the shareholding of its promoter and promoter group has diluted to 24.01% from 40.39% following the allotment of equity shares to shareholders of Quality Care India Limited (QCIL). The allotment was executed on July 13, 2026, pursuant to a Scheme of Amalgamation sanctioned by the National Company Law Tribunal, Hyderabad Bench. This restructuring increased the total equity share capital of Aster DM Quality Care Limited, formerly known as Aster DM Healthcare Limited, significantly altering the ownership structure.

The transaction involved an exchange ratio of 977 equity shares of Aster DM Quality Care Limited for every 1,000 equity shares held in QCIL. While the total number of shares held by the Aster Promoters remained constant at 20,92,83,923, the expansion of the company's equity base resulted in the dilution of their stake. The total equity share capital post-allotment rose to 87,16,72,439 shares from 51,81,21,029 shares prior to the transaction.

Shareholding Details

The disclosure was submitted in accordance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, due to a change in promoter shareholding exceeding 2%. The acquirer, BCP Asia II Topco IV Pte. Ltd., which is part of the Persons Acting in Concert (PAC), was also classified under the Promoter group in previous disclosures.

The filing confirmed that there are no shares held under encumbrance, nor are there any warrants or convertible securities involved in this transaction. The disclosure was signed by Dr. Azad Moopen, Executive Chairman & Promoter, on behalf of the Aster Promoters on July 14, 2026.

Aster DM Healthcare Limited has changed its name to Aster DM Quality Care Limited effective July 3, 2026, following the receipt of a fresh Certificate of Incorporation from the Registrar of Companies (RoC-Telangana). The name change is pursuant to Clause 21(i) of the Scheme of Amalgamation with Quality Care India Limited. The Ministry of Corporate Affairs certified the change, noting the company is limited by shares and originally incorporated as DM Healthcare Private Limited.

The merger, effective July 1, 2026, integrates four healthcare brands—Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH—across 39 hospitals in 28 cities with over 10,600 beds. The combined entity aims to expand specialist care and advanced medical technology into tier 2 and tier 3 cities such as Nagpur, Aurangabad, and Vijayawada. The authorized share capital stands at INR 1,051,70,00,000, divided into 98,20,00,000 equity shares of INR 10 each.

Leadership and Operations

Dr. Azad Moopen continues as Executive Chairman, while Mr. Varun Khanna leads the business as Managing Director and Group CEO. The leadership emphasized decentralizing affordable and advanced healthcare. The immediate priority is the seamless integration of systems to ensure continuity of patient care, leveraging shared protocols and multidisciplinary collaboration across the network. The entity employs more than 45,000 healthcare professionals.

Future Expansion

The group's combined bed strength is expected to grow to over 15,000 beds in the coming years. Future investments include advanced technologies such as Gamma Knife, stereotactic radiosurgery systems, and 10 robotic surgical platforms, alongside the addition of 12 LINAC-based radiation therapy systems in smaller cities. BCP Asia II Topco IV Pte. Limited has been categorized as a promoter shareholder effective July 1, 2026.